Infinity Pharmaceuticals Company Profile (NASDAQ:INFI)

About Infinity Pharmaceuticals

Infinity Pharmaceuticals logoInfinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The Company is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The Company also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: INFI
  • CUSIP: 45665G30
Key Metrics:
  • Previous Close: $1.46
  • 50 Day Moving Average: $1.56
  • 200 Day Moving Average: $3.50
  • 52-Week Range: $49,587,000.00 - $1.24
  • Trailing P/E Ratio: 4.69
  • Foreward P/E Ratio: -0.83
  • P/E Growth: -0.01
  • Market Cap: $72.40M
  • Outstanding Shares: 49,587,000
  • Beta: 1.67
Profitability:
  • Net Margins: 13.23%
  • Return on Equity: -55.51%
  • Return on Assets: -21.82%
Debt:
  • Debt-to-Equity Ratio: 0.16%
  • Current Ratio: 3.56%
  • Quick Ratio: 3.56%
Additional Links:
Companies Related to Infinity Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Infinity Pharmaceuticals (NASDAQ:INFI) (?)
Ratings Breakdown: 9 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.00 (242.47% upside)

Analysts' Ratings History for Infinity Pharmaceuticals (NASDAQ:INFI)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Morgan StanleyReiterated RatingHold$1.00View Rating Details
8/10/2016FBR & CoReiterated RatingHoldView Rating Details
8/9/2016WedbushReiterated RatingNeutral$1.25 -> $1.00View Rating Details
6/15/2016Jefferies GroupDowngradeBuy -> HoldView Rating Details
6/15/2016William BlairDowngradeOutperform -> Market Perform$20.00 -> $2.00View Rating Details
6/15/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
6/14/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$12.00 -> $2.00View Rating Details
6/14/2016JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
6/14/2016JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details
5/16/2015Stifel NicolausReiterated RatingHoldView Rating Details
5/10/2015NomuraReiterated RatingNeutral -> Buy$17.00 -> $13.00View Rating Details
5/6/2015Deutsche Bank AGInitiated CoverageBuy$20.00View Rating Details
12/4/2014Credit Suisse Group AGUpgradeNeutral -> Outperform$20.00 -> $22.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Infinity Pharmaceuticals (NASDAQ:INFI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/9/2016Q216($0.89)$1.05$13.91 million$9.47 millionViewListenView Earnings Details
5/4/2016Q116($0.82)($0.82)$8.80 million$9.26 millionViewListenView Earnings Details
2/23/2016Q415($0.72)($0.80)$18.26 million$9.10 millionViewListenView Earnings Details
11/5/2015Q315($0.63)$0.84$24.85 million$90.70 millionViewN/AView Earnings Details
8/6/2015Q215($1.00)($0.78)$5.83 million$4.90 millionViewN/AView Earnings Details
5/6/2015Q115($1.68)($1.91)$5.79 million$4.40 millionViewListenView Earnings Details
2/24/2015Q414($0.98)($0.83)$5.61 million$4.36 millionViewListenView Earnings Details
11/6/2014Q314$0.30$2.03$141.40 million$160.60 millionViewListenView Earnings Details
8/5/2014Q114($0.84)($0.78)ViewN/AView Earnings Details
5/6/2014Q1($0.83)($0.87)ViewListenView Earnings Details
2/25/2014Q413($0.87)($0.68)ViewListenView Earnings Details
11/7/2013($0.75)($0.71)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.62)($0.68)ViewListenView Earnings Details
11/6/2012Q312($0.57)$0.52$13.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Infinity Pharmaceuticals (NASDAQ:INFI)
Current Year EPS Consensus Estimate: $-1.53 EPS
Next Year EPS Consensus Estimate: $-1.76 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.91)($0.79)($0.85)
Q2 20164($1.02)($0.83)($0.92)
Q3 20164($0.93)($0.76)($0.88)
Q4 20164($1.04)($0.70)($0.90)
Q1 20171($0.13)($0.13)($0.13)
Q2 20171($0.12)($0.12)($0.12)
Q3 20171($0.13)($0.13)($0.13)
Q4 20171($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Infinity Pharmaceuticals (NASDAQ:INFI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Infinity Pharmaceuticals (NASDAQ:INFI)
Insider Ownership Percentage: 8.20%
Institutional Ownership Percentage: 80.86%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/25/2015Adelene Q PerkinsCEOSell5,000$10.93$54,650.00View SEC Filing  
6/15/2015Vito J PalombellaInsiderSell4,737$10.97$51,964.89View SEC Filing  
5/27/2015Adelene Q PerkinsCEOSell10,000$12.81$128,100.00View SEC Filing  
5/14/2015Adelene Q PerkinsCEOSell10,000$12.18$121,800.00View SEC Filing  
3/16/2015Adelene Q PerkinsCEOSell20,000$16.00$320,000.00View SEC Filing  
1/29/2015Adelene Q PerkinsCEOSell20,000$14.83$296,600.00View SEC Filing  
12/15/2014Vito J PalombellaInsiderSell4,737$16.32$77,307.84View SEC Filing  
11/26/2014Vito J PalombellaInsiderSell4,736$15.00$71,040.00View SEC Filing  
9/30/2014Anthony B EvninDirectorSell112,451$13.56$1,524,835.56View SEC Filing  
9/3/2014Vito J PalombellaInsiderSell9,472$15.39$145,774.08View SEC Filing  
11/27/2013Anthony B EvninDirectorSell163,864$14.82$2,428,464.48View SEC Filing  
9/13/2013Adelene PerkinsCEOSell45,000$20.72$932,400.00View SEC Filing  
6/20/2013Vito J PalombellaInsiderSell23,150$18.53$428,969.50View SEC Filing  
11/26/2012Christopher M LindblomInsiderSell13,885$25.73$357,261.05View SEC Filing  
9/7/2012Co BeaconMajor ShareholderBuy5,416,565$14.50$78,540,192.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Infinity Pharmaceuticals (NASDAQ:INFI)
DateHeadline
investornewswire.com logoEPS Estimate For Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Set At $-0.19 - Investor Newswire (NASDAQ:INFI)
www.investornewswire.com - September 24 at 5:12 PM
News IconKeen Investors Find News on Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 24 at 5:12 PM
News IconUnder the Microscope, Zeroing in at Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 22 at 3:40 PM
News IconPenny Stock Investors Keen on Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 22 at 8:48 AM
investornewswire.com logoCan Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Stock Hit Price Target Of $2? - Investor Newswire (NASDAQ:INFI)
www.investornewswire.com - September 21 at 9:49 AM
News IconPenny Stock Investors Take an Interest in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 21 at 9:49 AM
finance.yahoo.com logo11:36 am Infinity Pharmaceutical announces the publication of new findings by research collaborators at University of California San Diego School in the September 19 online issue of Nature (NASDAQ:INFI)
finance.yahoo.com - September 19 at 5:42 PM
publicnow.com logoInfinity Announces Publication On PI3K-Gamma In Nature (NASDAQ:INFI)
www.publicnow.com - September 19 at 5:42 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Frisco Fastball (NASDAQ:INFI)
friscofastball.com - September 18 at 10:03 AM
News IconEarnings Analysis & Update for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)? - Frisco Fastball (NASDAQ:INFI)
friscofastball.com - September 17 at 10:12 AM
News IconKeen Investors Seek Information on Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 16 at 5:29 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Stock - Frisco Fastball (NASDAQ:INFI)
friscofastball.com - September 16 at 9:34 AM
News IconStock Update, a Closer Look at Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 15 at 6:03 PM
News IconKeen Investors Narrowing Their Focus on Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Duncan Research (NASDAQ:INFI)
www.duncanindependent.com - September 14 at 5:46 PM
News IconWhat are Analysts Expecting for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Earnings? - Frisco Fastball (NASDAQ:INFI)
friscofastball.com - September 14 at 5:46 PM
News IconHC Stocks Growth= Biostar Pharmaceuticals Inc (BSPM), Infinity ... - share market updates (press release) (NASDAQ:INFI)
sharemarketupdates.com - September 14 at 5:46 PM
News Icon2 Biotech Stocks News And Price Trends: Cytokinetics, Incorporated (NASDAQ:CYTK), Infinity Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - September 8 at 9:33 AM
News IconPlacing Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Shares Under ... - Post News (NASDAQ:INFI)
www.kentuckypostnews.com - September 8 at 9:33 AM
News IconInfinity Pharmaceuticals, Inc Pipeline Review, Market Demand, Market Price, and Forecast 2016 - 2020 - Medgadget (blog) (NASDAQ:INFI)
www.medgadget.com - September 8 at 9:33 AM
News IconDecibel Therapeutics Expands Leadership Team (NASDAQ:INFI)
www.cbs58.com - September 7 at 9:03 AM
News IconPI3K still finding its way: Infinity, Zydelig hitches affirm challenge (NASDAQ:INFI)
www.bioworld.com - August 29 at 10:11 AM
News IconInfinity Pharmaceuticals, Inc. (NASDAQ:INFI) Shares in Focus According to the Crowd & Analysts - Post News (NASDAQ:INFI)
www.kentuckypostnews.com - August 25 at 10:40 AM
publicnow.com logoInfinis plc announces first quarter results for year ending 31.03.17 £350m 7% Senior Notes due 2019 (NASDAQ:INFI)
www.publicnow.com - August 25 at 10:40 AM
publicnow.com logoCall announcement Infinis plc 1st quarter results for the year ending 31 March 2017 £350m 7% Senior Notes due 2019 (NASDAQ:INFI)
www.publicnow.com - August 24 at 8:44 AM
finance.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Financials (NASDAQ:INFI)
finance.yahoo.com - August 19 at 5:38 PM
4-traders.com logoInfinity Pharmaceuticals : Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.4-traders.com - August 18 at 5:40 PM
investornewswire.com logoWill Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Surprise Analysts? - Investor Newswire (NASDAQ:INFI)
www.investornewswire.com - August 17 at 8:41 AM
News IconWorldwide Chondrosarcoma Treatment Market: Shifting Industry dynamics 2016 – 2022 (NASDAQ:INFI)
www.medgadget.com - August 16 at 5:47 PM
streetupdates.com logoMost Recent Analysts Ratings Report: Infinity Pharmaceuticals, Inc ... - Street Updates (NASDAQ:INFI)
www.streetupdates.com - August 10 at 8:31 AM
finance.yahoo.com logoEdited Transcript of INFI earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:INFI)
finance.yahoo.com - August 10 at 8:31 AM
cnbc.com logoInfinity beats 2Q profit forecasts (NASDAQ:INFI)
www.cnbc.com - August 9 at 5:47 PM
twst.com logoInfinity Pharmaceuticals Inc.: Infinity Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.twst.com - August 9 at 5:47 PM
publicnow.com logoInfinity Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.publicnow.com - August 9 at 5:47 PM
biz.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (NASDAQ:INFI)
biz.yahoo.com - August 9 at 5:47 PM
biz.yahoo.com logoInfinity Pharmaceuticals Inc Earnings Call (Q2 2016) (NASDAQ:INFI)
biz.yahoo.com - August 9 at 8:37 AM
News Icon3 Troubled Pharma Stocks That Could Rally Soon Volatile pharma stocks face critical earnings tests to prove they belong in the markets (NASDAQ:INFI)
www.minyanville.com - August 9 at 8:37 AM
biz.yahoo.com logoQ2 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:INFI)
biz.yahoo.com - August 9 at 8:37 AM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Jumps 5.42% on August 03 - Equities.com (NASDAQ:INFI)
www.equities.com - August 6 at 8:32 AM
fortune.com logoAnalyst Views To Note: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) - Review Fortune (NASDAQ:INFI)
reviewfortune.com - August 3 at 8:52 AM
News IconWhat Analyst's Think about Infinity Pharmaceuticals Inc. (NASDAQ:INFI) - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - August 3 at 8:52 AM
twst.com logoInfinity Pharmaceuticals Inc.: Infinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast (NASDAQ:INFI)
www.twst.com - August 2 at 5:53 PM
publicnow.com logoInfinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast (NASDAQ:INFI)
www.publicnow.com - August 2 at 10:28 AM
prnewswire.com logoResearch Report Coverage on Select Biotech Stocks -- Vertex Pharma, Infinity Pharma, Aduro BioTech, and Aralez Pharma (NASDAQ:INFI)
www.prnewswire.com - August 1 at 10:23 AM
biz.yahoo.com logoAbbVie Inc Earnings Call (Q2 2016) (NASDAQ:INFI)
biz.yahoo.com - July 29 at 8:34 AM
biz.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:INFI)
biz.yahoo.com - July 26 at 5:19 PM
marketwired.com logoPieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors (NASDAQ:INFI)
www.marketwired.com - July 26 at 8:36 AM
News IconBiotech news that matter for investors: Infinity Pharmaceuticals ... - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - July 23 at 9:39 AM
ftsenews.co.uk logoInfinity Pharmaceuticals, Inc. (NASDAQ:INFI) Updated Price Targets - FTSE News (NASDAQ:INFI)
www.ftsenews.co.uk - July 22 at 8:36 AM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Jumps 8.05% on July 20 - Equities.com (NASDAQ:INFI)
www.equities.com - July 20 at 10:00 PM
streetupdates.com logoAnalyst's Noticeable Buzzers: DexCom, Inc. (NASDAQ:DXCM) , Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Street Updates (NASDAQ:INFI)
www.streetupdates.com - July 20 at 3:39 PM

Social

Infinity Pharmaceuticals (NASDAQ:INFI) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff